About Us
- Contact Us
Our Technology
Our Science
- Pipeline
- Advantages of Gylden’s Candidates
News and Events
Menu Menu

You are here: Home1 / Conferences2 / Novel immunopeptidomic/machine learning integrated platform for next generation...

Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development

13th February 2025

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

/wp-content/uploads/2024/10/CompanyName-300x300.png 0 0 gatekeeper /wp-content/uploads/2024/10/CompanyName-300x300.png gatekeeper2025-02-13 13:07:542025-02-13 13:57:52Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development

© Gylden Pharma

Website maintained by Digital Trading

Contact Us

Progressing Next-Generation Vaccines using Hollow Microneedle Delivery – Results...Characterization of the immunogenic response of a Chikungunya virus T cell adaptive...